Similar Items: Scienter Potentia Est: The Case for the Presumption of Use Standard in Insider Trading
- Insider Trading in Crypto Assets—Back to First Principles?
- Speech Without Speakers: Eliminating Artificial Barriers to Pleading Corporate Scienter in Securities Fraud Claims
- Inside Views: Everything Is Obvious
- Inside Views: South Africa Moves Forward With Creator Rights Agenda
- Inside Views: Interview With Charles Gore, Medicines Patent Pool Executive Director
- Inventors, Licensing Groups Back US Withdrawal From Standards-Essential Patent Pact